FDA — authorised 14 September 1977
- Application: NDA017741
- Marketing authorisation holder: PFIZER
- Local brand name: FLORONE
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 Psorcon in United States
FDA authorised Psorcon on 14 September 1977
Marketing authorisations
FDA — authorised 14 September 1977
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: approved
FDA — authorised 1 March 1978
- Application: NDA017994
- Marketing authorisation holder: PFIZER
- Local brand name: PSORCON E
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 28 August 1985
- Application: NDA019260
- Marketing authorisation holder: PFIZER
- Local brand name: PSORCON
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 20 November 1992
- Application: NDA020205
- Marketing authorisation holder: TARO PHARMS NORTH
- Local brand name: PSORCON
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 30 March 1998
- Application: ANDA075187
- Marketing authorisation holder: AVONDALE PHARMS
- Local brand name: DIFLORASONE DIACETATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 27 April 1999
- Application: ANDA075374
- Marketing authorisation holder: AVONDALE PHARMS
- Local brand name: DIFLORASONE DIACETATE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 14 May 1999
- Application: ANDA075331
- Marketing authorisation holder: SUN PHARMA CANADA
- Local brand name: DIFLORASONE DIACETATE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 24 April 2000
- Application: ANDA075508
- Marketing authorisation holder: SUN PHARMA CANADA
- Local brand name: DIFLORASONE DIACETATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 20 December 2002
- Application: ANDA076263
- Marketing authorisation holder: ANI PHARMS
- Local brand name: DIFLORASONE DIACETATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 24 July 2015
- Application: ANDA206572
- Marketing authorisation holder: SCIEGEN PHARMS
- Local brand name: DIFLORASONE DIACETATE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 27 February 2017
- Application: ANDA207440
- Marketing authorisation holder: RISING
- Local brand name: DIFLORASONE DIACETATE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 12 June 2018
- Application: ANDA210753
- Marketing authorisation holder: THE J MOLNER
- Local brand name: DIFLORASONE DIACETATE
- Indication: OINTMENT — TOPICAL
- Status: approved
Psorcon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Psorcon approved in United States?
Yes. FDA authorised it on 14 September 1977; FDA authorised it on 14 September 1977; FDA authorised it on 1 March 1978.
Who is the marketing authorisation holder for Psorcon in United States?
PFIZER holds the US marketing authorisation.